Early, Personalized Cholesterol Screening and LDL-Lowering: What the New Guidelines Mean for Clinicians, Patients, and Payers
Episode Summary
New cholesterol guidelines emphasize earlier screening, personalized risk assessment, and aggressive LDL reduction, incorporating genetic factors like lipoprotein(a) to improve prevention, while raising cost, access, and overdiagnosis concerns.